GlassScriptPhysician profile
Sarika Sharma
NPI 1821042771
$9,034.46
in general payments reported to CMS, 2019-2025
43 companies · $995 in 2025
The $995 reported for 2025 was more than what 88% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,012 · 2020: $1,832 · 2021: $1,674 · 2022: $1,034 · 2023: $643 · 2024: $845 · 2025: $995.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,435 · Education: $47.77.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,435.46 |
| Education | $47.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,485.69 | 2019-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $1,002.93 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Kowa Pharmaceuticals America, INC. | $942.40 | 2019-2023 | Livalo, Seglentis |
| Novartis Pharmaceuticals Corporation | $922.43 | 2019-2025 | |
| Novo Nordisk INC | $800.61 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Bayer Healthcare Pharmaceuticals INC. | $572.43 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $460.02 | 2019-2024 | Xarelto |
| Pfizer INC. | $427.70 | 2019-2025 | |
| Arbor Pharmaceuticals, INC. | $383.82 | 2019-2022 | |
| Boston Scientific Corporation | $233.21 | 2020-2025 | Watchman Flx, Watchman, Watchman Access System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $221.56 | 2019-2025 | Jardiance |
| Digital Diagnostics INC. | $201.14 | 2019 | |
| Esperion Therapeutics, INC. | $129.90 | 2021-2025 | Nexletol |
| Abbott Laboratories | $118.29 | 2021-2025 | Freestyle Libre 3, Gallant |
| Lilly USA, LLC | $99.85 | 2019-2025 | Mounjaro |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch Health US, LLC | $96.76 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $77.10 | 2019 | |
| Althera Pharmaceuticals LLC | $73.99 | 2021-2022 | |
| Exact Sciences Corporation | $69.70 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Bridgebio Pharma, INC. | $68.95 | 2025 | Attruby |
| Allergan, INC. | $68.51 | 2019 | |
| Azurity Pharmaceuticals, INC. | $66.54 | 2023-2025 | Edarbi, Edarbi |
| E.R. Squibb & Sons, L.L.C. | $55.75 | 2019-2025 | Eliquis, Camzyos |
| Glaxosmithkline, LLC. | $54.91 | 2021-2025 | Arexvy, Shingrix |
| Medtronic, INC. | $39.39 | 2023-2025 | Minimed 770g, Symplicity G3 |
| Medtronic Minimed, INC. | $33.56 | 2019 | |
| Ani Pharmaceuticals, INC. | $31.41 | 2024 | Purified Cortrophin Gel |
| Kiniksa Pharmaceuticals International, Plc | $30.01 | 2024 | Arcalyst |
| Gilead Sciences, INC. | $27.41 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $25.56 | 2020-2024 | Trintellix |
| Amryt Pharma Holdings LTD | $25.55 | 2020-2021 | |
| Cvrx, INC. | $21.14 | 2025 | Barostim Neo System |
| Bardy Diagnostics, INC. | $20.00 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.78 | 2025 | Xifaxan |
| Abbvie INC. | $17.27 | 2023 | Avycaz |
| Corcept Therapeutics | $16.26 | 2025 | Korlym |
| Cleerly, INC. | $15.43 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Regeneron Healthcare Solutions, INC. | $14.39 | 2019 | |
| Radius Health, INC. | $14.38 | 2019 | |
| Horizon Therapeutics Plc | $13.75 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $13.50 | 2019 | |
| Phathom Pharmaceuticals, INC. | $12.18 | 2025 | Voquezna |
| Medicure Pharma INC. | $11.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarika Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.